MYXOID ROUND CELL LIPOSARCOMA
Clinical trials for MYXOID ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at multiple cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for people with certain cancers (bladder, melanoma, head/neck, ovarian, lung, esophageal, stomach, or sarcoma) whose tumors have a specific marker called MAGE-A4. The treatment involves taking a patient's own immune cells, …
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis study tests a new treatment using a patient's own immune cells that are genetically modified to better recognize and attack certain solid tumors. It is for people with advanced cancers like synovial sarcoma that have not responded to other treatments. The goal is to see if t…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Engineered immune cells take on rare sarcomas in new trial
Disease control OngoingThis phase 2 trial tests a treatment called Lete-Cel, which uses a patient's own immune cells that have been specially trained to attack cancer cells. It is for people with advanced synovial sarcoma or myxoid/round cell liposarcoma whose tumors have a specific marker (NY-ESO-1) a…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Designer immune cells take on rare sarcomas
Disease control OngoingThis phase 2 trial tests a personalized cell therapy called Lete-Cel in 7 people with advanced synovial sarcoma or myxoid/round cell liposarcoma that has not been treated before. Participants receive their own immune cells that have been engineered to recognize and attack their c…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM, LLC (dba US WorldMeds) • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Genetically modified t cells take on rare sarcomas
Disease control OngoingThis phase 2 trial tests a one-time infusion of a patient's own immune cells that have been genetically modified to recognize and attack cancer cells. It is for people with advanced synovial sarcoma or myxoid liposarcoma whose tumors have a specific marker (MAGE-A4) and who have …
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new treatment called BOXR1030 for people with advanced solid tumors that have a specific marker (GPC3). The treatment uses specially designed immune cells given after chemotherapy to help fight the cancer. The main goals are to check safety and find…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sotio Biotech Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC